32516360|t|Acute Nicotine Treatment Alleviates LPS-Induced Impairment of Fear Memory Reconsolidation Through AMPK Activation and CRTC1 Upregulation in Hippocampus.
32516360|a|BACKGROUND: Fear memory is a fundamental capability for animals and humans to survive. Its impairment results in the disability to avoid danger. When memory is reactivated, a reconsolidation process, which can be disrupted by various stimuli, including inflammation, is required to become permanent. Nicotine has been shown to improve cognitive deficits induced by inflammation and other stimuli. Therefore, in the present study, we investigated the effect of nicotine on lipopolysaccharide (LPS)-induced impairment of fear memory reconsolidation and the underlying mechanism. METHODS: Step-through inhibitory avoidance task was recruited to study fear memory of rat, i.p. LPS (0.5 mg/kg) treatment was used to induce inflammation, and western blot and immunostaining were applied to detect protein expression and distribution in medial prefrontal cortex and hippocampus. RESULTS: Our data showed that LPS induced fear memory reconsolidation impairment without affecting retrieval. In addition, LPS significantly increased inflammation factors tumor necrosis factor-alpha and interleukin-1 beta and decreased CREB-regulated transcription coactivator 1 (CRTC1) expression and adenosine monophosphate-activated protein kinase (AMPK) activation in hippocampus. More importantly, LPS significantly decreased CRTC1 expression and AMPK activation in neurons by activating microglia cells. Of note, either nicotine treatment or activation of AMPK by intracerebroventricular infusion of metformin reduced LPS-induced impairment of fear memory reconsolidation and ameliorated inflammation factor tumor necrosis factor-alpha and interleukin-1 beta as well as the expression of CRTC1. CONCLUSIONS: In conclusion, our results showed that acute nicotine treatment alleviates LPS-induced impairment of fear memory reconsolidation through activation of AMPK and upregulation of CRTC1 in hippocampus.
32516360	6	14	Nicotine	Chemical	MESH:D009538
32516360	36	39	LPS	Chemical	MESH:D008070
32516360	48	73	Impairment of Fear Memory	Disease	MESH:D008569
32516360	98	102	AMPK	Gene	78975
32516360	118	123	CRTC1	Gene	684527
32516360	165	176	Fear memory	Disease	MESH:C000719212
32516360	221	227	humans	Species	9606
32516360	244	254	impairment	Disease	MESH:D060825
32516360	406	418	inflammation	Disease	MESH:D007249
32516360	453	461	Nicotine	Chemical	MESH:D009538
32516360	488	506	cognitive deficits	Disease	MESH:D003072
32516360	518	530	inflammation	Disease	MESH:D007249
32516360	613	621	nicotine	Chemical	MESH:D009538
32516360	625	643	lipopolysaccharide	Chemical	MESH:D008070
32516360	645	648	LPS	Chemical	MESH:D008070
32516360	658	683	impairment of fear memory	Disease	MESH:D008569
32516360	801	812	fear memory	Disease	MESH:C000719212
32516360	816	819	rat	Species	10116
32516360	826	829	LPS	Chemical	MESH:D008070
32516360	871	883	inflammation	Disease	MESH:D007249
32516360	1055	1058	LPS	Chemical	MESH:D008070
32516360	1067	1078	fear memory	Disease	MESH:C000719212
32516360	1095	1105	impairment	Disease	MESH:D060825
32516360	1148	1151	LPS	Chemical	MESH:D008070
32516360	1176	1188	inflammation	Disease	MESH:D007249
32516360	1197	1224	tumor necrosis factor-alpha	Gene	24835
32516360	1229	1247	interleukin-1 beta	Gene	24494
32516360	1262	1304	CREB-regulated transcription coactivator 1	Gene	684527
32516360	1306	1311	CRTC1	Gene	684527
32516360	1328	1376	adenosine monophosphate-activated protein kinase	Gene	78975
32516360	1378	1382	AMPK	Gene	78975
32516360	1429	1432	LPS	Chemical	MESH:D008070
32516360	1457	1462	CRTC1	Gene	684527
32516360	1478	1482	AMPK	Gene	78975
32516360	1552	1560	nicotine	Chemical	MESH:D009538
32516360	1588	1592	AMPK	Gene	78975
32516360	1632	1641	metformin	Chemical	MESH:D008687
32516360	1650	1653	LPS	Chemical	MESH:D008070
32516360	1662	1687	impairment of fear memory	Disease	MESH:D008569
32516360	1720	1732	inflammation	Disease	MESH:D007249
32516360	1740	1767	tumor necrosis factor-alpha	Gene	24835
32516360	1772	1790	interleukin-1 beta	Gene	24494
32516360	1820	1825	CRTC1	Gene	684527
32516360	1885	1893	nicotine	Chemical	MESH:D009538
32516360	1915	1918	LPS	Chemical	MESH:D008070
32516360	1927	1952	impairment of fear memory	Disease	MESH:D008569
32516360	1991	1995	AMPK	Gene	78975
32516360	2016	2021	CRTC1	Gene	684527
32516360	Negative_Correlation	MESH:D008070	684527
32516360	Association	MESH:D008569	78975
32516360	Positive_Correlation	MESH:D009538	24494
32516360	Negative_Correlation	MESH:D008687	24494
32516360	Positive_Correlation	24835	78975
32516360	Positive_Correlation	MESH:D008070	24835
32516360	Positive_Correlation	MESH:D009538	78975
32516360	Positive_Correlation	MESH:D009538	24835
32516360	Negative_Correlation	MESH:D009538	MESH:D008569
32516360	Negative_Correlation	MESH:D008687	MESH:D007249
32516360	Positive_Correlation	MESH:D009538	684527
32516360	Negative_Correlation	MESH:D009538	MESH:D003072
32516360	Positive_Correlation	MESH:D008070	MESH:D060825
32516360	Positive_Correlation	684527	78975
32516360	Association	MESH:D008569	684527
32516360	Positive_Correlation	MESH:D008687	78975
32516360	Positive_Correlation	MESH:D008070	MESH:D007249
32516360	Positive_Correlation	MESH:D008070	24494
32516360	Positive_Correlation	MESH:D008070	MESH:C000719212
32516360	Negative_Correlation	MESH:D008687	684527
32516360	Negative_Correlation	MESH:D009538	MESH:D007249
32516360	Association	MESH:D007249	24494
32516360	Negative_Correlation	MESH:D008070	MESH:D008687
32516360	Negative_Correlation	MESH:D008070	78975
32516360	Association	MESH:D007249	24835
32516360	Negative_Correlation	MESH:D008687	24835
32516360	Negative_Correlation	MESH:D008687	MESH:D008569
32516360	Negative_Correlation	MESH:D008070	MESH:D009538
32516360	Positive_Correlation	MESH:D008070	MESH:D008569
32516360	Positive_Correlation	24494	78975

